Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharming Group NV
Long-Term Debt Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Long-Term Debt
$119.9m
CAGR 3-Years
-5%
CAGR 5-Years
38%
CAGR 10-Years
60%
ProQR Therapeutics NV
NASDAQ:PRQR
Long-Term Debt
€13.1m
CAGR 3-Years
-26%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Long-Term Debt
$477.8m
CAGR 3-Years
88%
CAGR 5-Years
68%
CAGR 10-Years
37%
argenx SE
XBRU:ARGX
Long-Term Debt
$28.1m
CAGR 3-Years
85%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Long-Term Debt
$591k
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Long-Term Debt?
Long-Term Debt
119.9m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Long-Term Debt amounts to 119.9m USD.

What is Pharming Group NV's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
60%

Over the last year, the Long-Term Debt growth was -24%. The average annual Long-Term Debt growth rates for Pharming Group NV have been -5% over the past three years , 38% over the past five years , and 60% over the past ten years .

Back to Top